Does Aged Garlic Extract Reverse Plaque? What the Scans Show
A headline has been circulating for years that aged garlic extract cut arterial plaque buildup by 80 percent. It is a remarkable number, and it comes from a real randomized trial, which is more than most supplement claims can say. The trouble is that the 80 percent is not in the trial. So the honest question is narrower than the headline: does aged garlic extract reverse plaque, and if it moves anything, what exactly does it move?
The answer is more interesting than either the hype or the dismissal. There is a genuine, repeatable finding here. There is also a press release that turned a result the authors reported as not significant into the number everyone now quotes.
What Is Aged Garlic Extract?
Aged garlic extract is made by steeping sliced garlic in dilute ethanol for up to 20 months. The aging converts the sharp, unstable compounds in raw garlic, the ones responsible for the smell and the stomach upset, into milder, water-soluble sulfur compounds such as S-allylcysteine. The result is standardized, far gentler on the gut than raw garlic, and the specific preparation that most of the cardiovascular research has used.
That research matters because garlic has one of the longest histories of any heart-health folk remedy, and most of it is weak. Aged garlic extract is the version that got put through actual imaging trials, where researchers photograph the coronary arteries at the start and again a year later and measure what changed. That is a much harder test than asking whether a blood marker moved, and it is the test this article is about.
The Science: Does Aged Garlic Extract Reverse Plaque?
Two randomized, double-blind trials from the same research group used CT angiography to track coronary plaque in people taking aged garlic extract or placebo. Read together, they tell a consistent and specific story, and they also show exactly where the popular version of that story goes wrong.
A real imaging trial found soft plaque regressed
The main study is the one the 80 percent headline is built on, so it is worth stating precisely what it found.
- The Evidence: A prospective, randomized, double-blind study led by the Budoff group at Harbor-UCLA enrolled 55 people with metabolic syndrome and gave them either 2,400 mg of aged garlic extract a day or a placebo, with cardiac CT angiography at baseline and again about a year later. The change in low-attenuation plaque, the soft, lipid-rich kind considered most likely to rupture, was significantly better in the garlic group than in the placebo group, falling 1.5 percent against a small rise of 0.2 percent (p equals 0.0049). After adjusting for other risk factors, the benefit held up.
- Read the study: Aged Garlic Extract Reduces Low Attenuation Plaque in Coronary Arteries of Patients with Metabolic Syndrome
That is a legitimate result, from the type of study that can actually support a cause-and-effect claim. The effect was specific to soft plaque, which is the fraction most responsive to change over a single year, and it is a reasonable reason someone might consider the supplement.
It replicated in people with diabetes
A single trial in one population is a lead, not a conclusion. The same group ran a second one.
- The Evidence: A later randomized, double-blind, placebo-controlled study applied the same design to 69 people with type 2 diabetes, again 2,400 mg of aged garlic extract a day against placebo, with CT angiography a year apart. Soft plaque regressed in the garlic group while it progressed on placebo (p equals 0.045). As in the first trial, the benefit was confined to the low-attenuation fraction, with no significant change in total plaque.
- Read the study: Aged garlic extract reduces low attenuation plaque in coronary arteries of patients with diabetes
Two trials pointing the same way, in two different patient groups, is a stronger signal than one. It also sharpens the point: both studies found the same narrow effect, and both found it only in soft plaque.
The viral 80 percent is a misread of a result that was not significant
Here is where the popular telling parts company with the paper. If you search this topic, you will find that aged garlic extract “slowed total plaque accumulation by 80 percent.” Compare that to what the study actually reported.
- The Evidence: In the metabolic syndrome trial, the change in total plaque volume was roughly 0.3 percent in the garlic group against 1.6 percent on placebo, and that difference was not statistically significant (p equals 0.13). Non-calcified plaque was also not significant, and dense calcium did not move at all (p equals 0.99). The soft plaque result was the one finding that reached significance. The 80 percent figure appears in the 2016 press release about the study, not in the paper, and it is a relative framing of the total-plaque difference the authors themselves reported as null.
- Read the study: New study shows aged garlic extract can reduce dangerous plaque buildup in arteries (press release)
Turning 1.6 versus 0.3 into “80 percent less” is arithmetically true and scientifically misleading, because a difference that fails its own significance test is one you are not entitled to quote as a result. This is the same trap that runs through the honest corners of the supplement shelf, from the single study behind the 10,800 FU nattokinase dose to the way press releases tend to launder a secondary or non-significant number into the headline. Reading the primary paper rather than the coverage is what catches it.
A Practical Guide: How to Use It
If you want to match the evidence, the dose is not a guess. Both imaging trials used 2,400 mg of aged garlic extract a day, taken for about a year, and both used the Kyolic preparation rather than raw garlic or garlic oil. The product here is that line, which is why it is the pick over a cheaper raw garlic capsule: the form and the dose are what the studies actually tested.
Set your expectations to the finding, though, not the headline. What these trials support is a modest regression in soft plaque over a year in people who already have metabolic syndrome or diabetes, which is a specific group at elevated cardiovascular risk. They do not support the idea that garlic clears out calcified plaque or shrinks total plaque burden, and they say nothing about whether any of this lowers the risk of a heart attack, which no trial has yet measured. Aged garlic extract is a reasonable adjunct for someone in that risk group who wants to act on the soft-plaque data. It is not a reason to skip the measures that genuinely move cardiovascular risk, such as blood pressure control, not smoking, exercise, and a statin where one is indicated.
Safety and Advice
Aged garlic extract is one of the better-tolerated supplements on the shelf, and the aging process strips out most of what makes raw garlic hard on the stomach. The caution that matters is the same one that applies to garlic generally: it has a mild antiplatelet, blood-thinning action. That is not a problem for most people on its own, but it can add up with anticoagulants such as warfarin, with antiplatelet drugs, or with regular aspirin, so it is worth clearing with a doctor first if you take any of those. Stop it well before surgery or a dental procedure for the same reason.
Beyond that, the usual sense applies. It is not a substitute for prescribed cardiovascular treatment, the evidence sits in specific higher-risk groups rather than the general population, and anyone who is pregnant, breastfeeding, or managing a bleeding disorder should check before starting.
The Bottom Line
Aged garlic extract has something most supplements lack: two randomized imaging trials, from a credible academic group, showing a real effect. That effect is narrow. It regressed soft, low-attenuation plaque in people with metabolic syndrome or diabetes, and it did not significantly change total plaque, non-calcified plaque, or calcium. The famous 80 percent reduction is a press-release gloss on a result the paper reported as not significant, and it should not be the reason anyone buys this.
If you are in one of those higher-risk groups and want to act on the soft-plaque data, the 2,400 mg a day used in the trials is the dose to match, with the understanding that you are treating one changeable fraction of plaque, not reversing arterial disease. Read the trial, not the headline, and keep the expectation the size the evidence actually is.
This article is for educational purposes only and is not medical advice. Supplements can interact with medications and health conditions, so talk to a qualified healthcare provider before starting anything new.
Common questions
Does aged garlic extract reverse plaque?
In two randomized imaging trials it reduced one specific kind, soft or low-attenuation plaque, compared with placebo over about a year. It did not reduce total plaque volume or arterial calcium. So it nudged the softest, most changeable fraction rather than reversing plaque in general.
Where does the 80 percent plaque reduction figure come from?
From a 2016 press release about the trial, not from the trial itself. The paper reported a difference in total plaque of roughly 0.3 percent against 1.6 percent, which was not statistically significant (p equals 0.13). The 80 percent is a relative framing of a result the authors did not count as real.
What dose of aged garlic extract did the research use?
Both imaging trials used 2,400 mg a day of aged garlic extract for about 12 months, given against a matching placebo and tracked with CT angiography.
Is aged garlic extract safe to take?
It is generally well tolerated, and aged garlic is lower in the harsh compounds of raw garlic. The main caution is a mild blood thinning effect, so talk to a doctor before combining it with anticoagulants, antiplatelet drugs, or aspirin, and stop it before surgery.